OBJECTIVE: A measure that identifies patients who are at high risk of mortality after prolonged ventilation will help physicians communicate prognoses to patients or surrogate decision makers. Our objective was to develop and validate a prognostic model for 1-yr mortality in patients ventilated for 21 days or more. DESIGN: The authors conducted a prospective cohort study. SETTING: The study took place at a university-based tertiary care hospital. PATIENTS: Three hundred consecutive medical, surgical, and trauma patients requiring mechanical ventilation for at least 21 days were prospectively enrolled. MEASUREMENTS AND MAIN RESULTS: Predictive variables were measured on day 21 of ventilation for the first 200 patients and entered into logistic regression models with 1-yr and 3-mo mortality as outcomes. Final models were validated using data from 100 subsequent patients. One-year mortality was 51% in the development set and 58% in the validation set. Independent predictors of mortality included requirement for vasopressors, hemodialysis, platelet count < or = 150 x 10(9)/L, and age > or = 50 yrs. Areas under the receiver operating characteristic curve for the development model and validation model were .82 (SE .03) and .82 (SE .05), respectively. The model had sensitivity of .42 (SE .12) and specificity of .99 (SE .01) for identifying patients who had > or = 90% risk of death at 1 yr. Observed mortality was highly consistent with both 3- and 12-mo predicted mortality. These four predictive variables can be used in a simple prognostic score that clearly identifies low-risk patients (no risk factors, 15% mortality) and high-risk patients (three or four risk factors, 97% mortality). CONCLUSIONS: Simple clinical variables measured on day 21 of mechanical ventilation can identify patients at highest and lowest risk of death from prolonged ventilation.
OBJECTIVE: A measure that identifies patients who are at high risk of mortality after prolonged ventilation will help physicians communicate prognoses to patients or surrogate decision makers. Our objective was to develop and validate a prognostic model for 1-yr mortality in patients ventilated for 21 days or more. DESIGN: The authors conducted a prospective cohort study. SETTING: The study took place at a university-based tertiary care hospital. PATIENTS: Three hundred consecutive medical, surgical, and traumapatients requiring mechanical ventilation for at least 21 days were prospectively enrolled. MEASUREMENTS AND MAIN RESULTS: Predictive variables were measured on day 21 of ventilation for the first 200 patients and entered into logistic regression models with 1-yr and 3-mo mortality as outcomes. Final models were validated using data from 100 subsequent patients. One-year mortality was 51% in the development set and 58% in the validation set. Independent predictors of mortality included requirement for vasopressors, hemodialysis, platelet count < or = 150 x 10(9)/L, and age > or = 50 yrs. Areas under the receiver operating characteristic curve for the development model and validation model were .82 (SE .03) and .82 (SE .05), respectively. The model had sensitivity of .42 (SE .12) and specificity of .99 (SE .01) for identifying patients who had > or = 90% risk of death at 1 yr. Observed mortality was highly consistent with both 3- and 12-mo predicted mortality. These four predictive variables can be used in a simple prognostic score that clearly identifies low-risk patients (no risk factors, 15% mortality) and high-risk patients (three or four risk factors, 97% mortality). CONCLUSIONS: Simple clinical variables measured on day 21 of mechanical ventilation can identify patients at highest and lowest risk of death from prolonged ventilation.
Authors: Neil R MacIntyre; Scott K Epstein; Shannon Carson; David Scheinhorn; Kent Christopher; Sean Muldoon Journal: Chest Date: 2005-12 Impact factor: 9.410
Authors: J L Vincent; A de Mendonça; F Cantraine; R Moreno; J Takala; P M Suter; C L Sprung; F Colardyn; S Blecher Journal: Crit Care Med Date: 1998-11 Impact factor: 7.598
Authors: Deborah Cook; Graeme Rocker; John Marshall; Peter Sjokvist; Peter Dodek; Lauren Griffith; Andreas Freitag; Joseph Varon; Christine Bradley; Mitchell Levy; Simon Finfer; Cindy Hamielec; Joseph McMullin; Bruce Weaver; Stephen Walter; Gordon Guyatt Journal: N Engl J Med Date: 2003-09-18 Impact factor: 91.245
Authors: Mark Unroe; Jeremy M Kahn; Shannon S Carson; Joseph A Govert; Tereza Martinu; Shailaja J Sathy; Alison S Clay; Jessica Chia; Alice Gray; James A Tulsky; Christopher E Cox Journal: Ann Intern Med Date: 2010-08-03 Impact factor: 25.391
Authors: Christopher E Cox; Tereza Martinu; Shailaja J Sathy; Alison S Clay; Jessica Chia; Alice L Gray; Maren K Olsen; Joseph A Govert; Shannon S Carson; James A Tulsky Journal: Crit Care Med Date: 2009-11 Impact factor: 7.598
Authors: Amal Jubran; Brydon J B Grant; Lisa A Duffner; Eileen G Collins; Dorothy M Lanuza; Leslie A Hoffman; Martin J Tobin Journal: JAMA Date: 2013-02-20 Impact factor: 56.272